Kontigo Care KONT.ST · SEK

Its shares trade on Nasdaq Stockholm under the ticker KONT.ST. It has been listed since 23 June 2015. In the fiscal year to 31 December 2025, it reported revenue of SEK 29.1m and a net loss of SEK 2.1m. At that date it held total assets of SEK 62.1m and shareholders' equity of SEK 50.5m.

Kontigo Care AB engages in the development of mobile health solutions for addiction treatment. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2015-06-23. The firm operates as a provider of mobile solutions for the treatment of alcoholism. The firm develops TripleA which is a system of care for the treatment of alcoholism. The system consists of a wireless breathalyzer, an application and a health care portal. The portal creates patient care plan and shares it with health care provider. On the basis of this plan, the patient receives information about scheduled sobriety test. Test results are then sent back to the health care provider who can monitor the patient's sobriety every day. The firm operates domestically on the territory of Sweden.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Alex StendahlIndependent Chairman of the Board
• Ms. Ulrika GiersChief Executive Officer
• Mr. Olle QvarnstromIndependent Deputy Chairman of the Board
• Ms. Anja PetersChief Financial Officer
• Mr. Markku HamalainenHead of ResearchSEK 1.1m
• Mr. Fredrik RemaeusSoftware Manager
• Ms. Maria WinkvistProduct Manager
• Mr. Matthias DurnerIndependent Director
• Mr. Jan LarssonIndependent Director
• Mr. Pontus NobreusIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.